German Pharma Co. Says Takeda's ADHD Drug IP Isn't Valid
The German pharmaceuticals company Aristo has asked a London court to invalidate Takeda's extended patent protections in the U.K. over the ADHD treatment Elvanse....To view the full article, register now.
Already a subscriber? Click here to view full article